The Great Cholesterol Scam and the Dangers of Statins
The article argues that the widespread use of statins and the demonization of cholesterol are driven by pharmaceutical profit rather than science. It claims high cholesterol is not a direct cause of heart disease and that statins carry dangerous side effects, suggesting the cholesterol-lowering industry is a scam.
Background
- Dr. Aseem Malhotra is a British cardiologist who argues the link between dietary cholesterol and heart disease has been overstated and promotes a low-carb, high-fat diet. Mainstream medical bodies have criticized him for selective use of evidence.
- Statins (e.g., atorvastatin) lower LDL cholesterol and are among the most-prescribed drugs worldwide. Large trials show they reduce heart attacks and strokes in high-risk patients, and major cardiology societies endorse their use.
- The "cholesterol scam" narrative claims the cholesterol-heart disease hypothesis was manufactured to sell statins to healthy people — a view that contradicts the consensus of regulators (FDA, EMA) and clinical trial evidence.
- Critics of this article note Malhotra downplays statins' mortality benefit for those who already had a heart attack and exaggerates side effects like muscle pain, which placebo trials show are mostly nocebo effects (patients expect harm).